Treatment Considerations for the Depressed Geriatric Medical Patient
Summary Depression is one of the most common reversible psychiatric disorders in the medically ill hospitalised elderly. Because of its adverse impact on quality of life, compliance with medical therapy, motivation towards recovery, and survival itself, depression requires rapid diagnosis and compre...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Koenig, Harold G. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
1991 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
Enthalten in: Drugs & aging - Berlin [u.a.] : Springer, 1991, 1(1991), 4 vom: Juli, Seite 266-278 |
|---|---|
| Übergeordnetes Werk: |
volume:1 ; year:1991 ; number:4 ; month:07 ; pages:266-278 |
| Links: |
|---|
| DOI / URN: |
10.2165/00002512-199101040-00003 |
|---|
| Katalog-ID: |
SPR03322515X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR03322515X | ||
| 003 | DE-627 | ||
| 005 | 20230519172912.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201007s1991 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2165/00002512-199101040-00003 |2 doi | |
| 035 | |a (DE-627)SPR03322515X | ||
| 035 | |a (SPR)00002512-199101040-00003-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q ASE |
| 100 | 1 | |a Koenig, Harold G. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Treatment Considerations for the Depressed Geriatric Medical Patient |
| 264 | 1 | |c 1991 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Summary Depression is one of the most common reversible psychiatric disorders in the medically ill hospitalised elderly. Because of its adverse impact on quality of life, compliance with medical therapy, motivation towards recovery, and survival itself, depression requires rapid diagnosis and comprehensive management. Because of the risks attendant on the use of antidepressants and electroconvulsive therapy (ECT) in this population, medical and psychosocial strategies are of paramount and primary importance in the treatment of most critically ill depressed elderly individuals. These include adequate treatment of reversible medical illness, provision of psychological support, mobilisation of community resources, and involvement of family and social support networks. When depression is severe or associated with marked suicidal ideation, however, these four strategies may need to be carried out concurrently with biological therapies. After ensuring adequate cardiac, liver, and renal function, antidepressant therapy is best initiated at a low dosage (secondary amine preferred) and gradually titrated upward following serum concentrations carefully and monitoring for anticholinergic, hypotensive and cardiac adverse effects. If antidepressant therapy is not tolerated or is unsuccessful, then psychiatric consultation should be obtained and ECT considered, particularly if the patient is well enough to undergo repeated episodes of brief general anaesthesia. | ||
| 650 | 4 | |a Fluoxetine |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Bupropion |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Desipramine |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Biological Therapy |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Nortriptyline |7 (dpeaa)DE-He213 | |
| 773 | 0 | 8 | |i Enthalten in |t Drugs & aging |d Berlin [u.a.] : Springer, 1991 |g 1(1991), 4 vom: Juli, Seite 266-278 |w (DE-627)327644281 |w (DE-600)2043689-0 |x 1179-1969 |7 nnns |
| 773 | 1 | 8 | |g volume:1 |g year:1991 |g number:4 |g month:07 |g pages:266-278 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.2165/00002512-199101040-00003 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a SSG-OPC-ASE | ||
| 912 | |a GBV_ILN_702 | ||
| 912 | |a GBV_ILN_2190 | ||
| 951 | |a AR | ||
| 952 | |d 1 |j 1991 |e 4 |c 07 |h 266-278 | ||
| author_variant |
h g k hg hgk |
|---|---|
| matchkey_str |
article:11791969:1991----::ramncnieainfrhdpesdeit |
| hierarchy_sort_str |
1991 |
| publishDate |
1991 |
| allfields |
10.2165/00002512-199101040-00003 doi (DE-627)SPR03322515X (SPR)00002512-199101040-00003-e DE-627 ger DE-627 rakwb eng 610 ASE Koenig, Harold G. verfasserin aut Treatment Considerations for the Depressed Geriatric Medical Patient 1991 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Summary Depression is one of the most common reversible psychiatric disorders in the medically ill hospitalised elderly. Because of its adverse impact on quality of life, compliance with medical therapy, motivation towards recovery, and survival itself, depression requires rapid diagnosis and comprehensive management. Because of the risks attendant on the use of antidepressants and electroconvulsive therapy (ECT) in this population, medical and psychosocial strategies are of paramount and primary importance in the treatment of most critically ill depressed elderly individuals. These include adequate treatment of reversible medical illness, provision of psychological support, mobilisation of community resources, and involvement of family and social support networks. When depression is severe or associated with marked suicidal ideation, however, these four strategies may need to be carried out concurrently with biological therapies. After ensuring adequate cardiac, liver, and renal function, antidepressant therapy is best initiated at a low dosage (secondary amine preferred) and gradually titrated upward following serum concentrations carefully and monitoring for anticholinergic, hypotensive and cardiac adverse effects. If antidepressant therapy is not tolerated or is unsuccessful, then psychiatric consultation should be obtained and ECT considered, particularly if the patient is well enough to undergo repeated episodes of brief general anaesthesia. Fluoxetine (dpeaa)DE-He213 Bupropion (dpeaa)DE-He213 Desipramine (dpeaa)DE-He213 Biological Therapy (dpeaa)DE-He213 Nortriptyline (dpeaa)DE-He213 Enthalten in Drugs & aging Berlin [u.a.] : Springer, 1991 1(1991), 4 vom: Juli, Seite 266-278 (DE-627)327644281 (DE-600)2043689-0 1179-1969 nnns volume:1 year:1991 number:4 month:07 pages:266-278 https://dx.doi.org/10.2165/00002512-199101040-00003 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA SSG-OPC-PHA SSG-OPC-ASE GBV_ILN_702 GBV_ILN_2190 AR 1 1991 4 07 266-278 |
| spelling |
10.2165/00002512-199101040-00003 doi (DE-627)SPR03322515X (SPR)00002512-199101040-00003-e DE-627 ger DE-627 rakwb eng 610 ASE Koenig, Harold G. verfasserin aut Treatment Considerations for the Depressed Geriatric Medical Patient 1991 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Summary Depression is one of the most common reversible psychiatric disorders in the medically ill hospitalised elderly. Because of its adverse impact on quality of life, compliance with medical therapy, motivation towards recovery, and survival itself, depression requires rapid diagnosis and comprehensive management. Because of the risks attendant on the use of antidepressants and electroconvulsive therapy (ECT) in this population, medical and psychosocial strategies are of paramount and primary importance in the treatment of most critically ill depressed elderly individuals. These include adequate treatment of reversible medical illness, provision of psychological support, mobilisation of community resources, and involvement of family and social support networks. When depression is severe or associated with marked suicidal ideation, however, these four strategies may need to be carried out concurrently with biological therapies. After ensuring adequate cardiac, liver, and renal function, antidepressant therapy is best initiated at a low dosage (secondary amine preferred) and gradually titrated upward following serum concentrations carefully and monitoring for anticholinergic, hypotensive and cardiac adverse effects. If antidepressant therapy is not tolerated or is unsuccessful, then psychiatric consultation should be obtained and ECT considered, particularly if the patient is well enough to undergo repeated episodes of brief general anaesthesia. Fluoxetine (dpeaa)DE-He213 Bupropion (dpeaa)DE-He213 Desipramine (dpeaa)DE-He213 Biological Therapy (dpeaa)DE-He213 Nortriptyline (dpeaa)DE-He213 Enthalten in Drugs & aging Berlin [u.a.] : Springer, 1991 1(1991), 4 vom: Juli, Seite 266-278 (DE-627)327644281 (DE-600)2043689-0 1179-1969 nnns volume:1 year:1991 number:4 month:07 pages:266-278 https://dx.doi.org/10.2165/00002512-199101040-00003 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA SSG-OPC-PHA SSG-OPC-ASE GBV_ILN_702 GBV_ILN_2190 AR 1 1991 4 07 266-278 |
| allfields_unstemmed |
10.2165/00002512-199101040-00003 doi (DE-627)SPR03322515X (SPR)00002512-199101040-00003-e DE-627 ger DE-627 rakwb eng 610 ASE Koenig, Harold G. verfasserin aut Treatment Considerations for the Depressed Geriatric Medical Patient 1991 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Summary Depression is one of the most common reversible psychiatric disorders in the medically ill hospitalised elderly. Because of its adverse impact on quality of life, compliance with medical therapy, motivation towards recovery, and survival itself, depression requires rapid diagnosis and comprehensive management. Because of the risks attendant on the use of antidepressants and electroconvulsive therapy (ECT) in this population, medical and psychosocial strategies are of paramount and primary importance in the treatment of most critically ill depressed elderly individuals. These include adequate treatment of reversible medical illness, provision of psychological support, mobilisation of community resources, and involvement of family and social support networks. When depression is severe or associated with marked suicidal ideation, however, these four strategies may need to be carried out concurrently with biological therapies. After ensuring adequate cardiac, liver, and renal function, antidepressant therapy is best initiated at a low dosage (secondary amine preferred) and gradually titrated upward following serum concentrations carefully and monitoring for anticholinergic, hypotensive and cardiac adverse effects. If antidepressant therapy is not tolerated or is unsuccessful, then psychiatric consultation should be obtained and ECT considered, particularly if the patient is well enough to undergo repeated episodes of brief general anaesthesia. Fluoxetine (dpeaa)DE-He213 Bupropion (dpeaa)DE-He213 Desipramine (dpeaa)DE-He213 Biological Therapy (dpeaa)DE-He213 Nortriptyline (dpeaa)DE-He213 Enthalten in Drugs & aging Berlin [u.a.] : Springer, 1991 1(1991), 4 vom: Juli, Seite 266-278 (DE-627)327644281 (DE-600)2043689-0 1179-1969 nnns volume:1 year:1991 number:4 month:07 pages:266-278 https://dx.doi.org/10.2165/00002512-199101040-00003 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA SSG-OPC-PHA SSG-OPC-ASE GBV_ILN_702 GBV_ILN_2190 AR 1 1991 4 07 266-278 |
| allfieldsGer |
10.2165/00002512-199101040-00003 doi (DE-627)SPR03322515X (SPR)00002512-199101040-00003-e DE-627 ger DE-627 rakwb eng 610 ASE Koenig, Harold G. verfasserin aut Treatment Considerations for the Depressed Geriatric Medical Patient 1991 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Summary Depression is one of the most common reversible psychiatric disorders in the medically ill hospitalised elderly. Because of its adverse impact on quality of life, compliance with medical therapy, motivation towards recovery, and survival itself, depression requires rapid diagnosis and comprehensive management. Because of the risks attendant on the use of antidepressants and electroconvulsive therapy (ECT) in this population, medical and psychosocial strategies are of paramount and primary importance in the treatment of most critically ill depressed elderly individuals. These include adequate treatment of reversible medical illness, provision of psychological support, mobilisation of community resources, and involvement of family and social support networks. When depression is severe or associated with marked suicidal ideation, however, these four strategies may need to be carried out concurrently with biological therapies. After ensuring adequate cardiac, liver, and renal function, antidepressant therapy is best initiated at a low dosage (secondary amine preferred) and gradually titrated upward following serum concentrations carefully and monitoring for anticholinergic, hypotensive and cardiac adverse effects. If antidepressant therapy is not tolerated or is unsuccessful, then psychiatric consultation should be obtained and ECT considered, particularly if the patient is well enough to undergo repeated episodes of brief general anaesthesia. Fluoxetine (dpeaa)DE-He213 Bupropion (dpeaa)DE-He213 Desipramine (dpeaa)DE-He213 Biological Therapy (dpeaa)DE-He213 Nortriptyline (dpeaa)DE-He213 Enthalten in Drugs & aging Berlin [u.a.] : Springer, 1991 1(1991), 4 vom: Juli, Seite 266-278 (DE-627)327644281 (DE-600)2043689-0 1179-1969 nnns volume:1 year:1991 number:4 month:07 pages:266-278 https://dx.doi.org/10.2165/00002512-199101040-00003 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA SSG-OPC-PHA SSG-OPC-ASE GBV_ILN_702 GBV_ILN_2190 AR 1 1991 4 07 266-278 |
| allfieldsSound |
10.2165/00002512-199101040-00003 doi (DE-627)SPR03322515X (SPR)00002512-199101040-00003-e DE-627 ger DE-627 rakwb eng 610 ASE Koenig, Harold G. verfasserin aut Treatment Considerations for the Depressed Geriatric Medical Patient 1991 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Summary Depression is one of the most common reversible psychiatric disorders in the medically ill hospitalised elderly. Because of its adverse impact on quality of life, compliance with medical therapy, motivation towards recovery, and survival itself, depression requires rapid diagnosis and comprehensive management. Because of the risks attendant on the use of antidepressants and electroconvulsive therapy (ECT) in this population, medical and psychosocial strategies are of paramount and primary importance in the treatment of most critically ill depressed elderly individuals. These include adequate treatment of reversible medical illness, provision of psychological support, mobilisation of community resources, and involvement of family and social support networks. When depression is severe or associated with marked suicidal ideation, however, these four strategies may need to be carried out concurrently with biological therapies. After ensuring adequate cardiac, liver, and renal function, antidepressant therapy is best initiated at a low dosage (secondary amine preferred) and gradually titrated upward following serum concentrations carefully and monitoring for anticholinergic, hypotensive and cardiac adverse effects. If antidepressant therapy is not tolerated or is unsuccessful, then psychiatric consultation should be obtained and ECT considered, particularly if the patient is well enough to undergo repeated episodes of brief general anaesthesia. Fluoxetine (dpeaa)DE-He213 Bupropion (dpeaa)DE-He213 Desipramine (dpeaa)DE-He213 Biological Therapy (dpeaa)DE-He213 Nortriptyline (dpeaa)DE-He213 Enthalten in Drugs & aging Berlin [u.a.] : Springer, 1991 1(1991), 4 vom: Juli, Seite 266-278 (DE-627)327644281 (DE-600)2043689-0 1179-1969 nnns volume:1 year:1991 number:4 month:07 pages:266-278 https://dx.doi.org/10.2165/00002512-199101040-00003 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA SSG-OPC-PHA SSG-OPC-ASE GBV_ILN_702 GBV_ILN_2190 AR 1 1991 4 07 266-278 |
| language |
English |
| source |
Enthalten in Drugs & aging 1(1991), 4 vom: Juli, Seite 266-278 volume:1 year:1991 number:4 month:07 pages:266-278 |
| sourceStr |
Enthalten in Drugs & aging 1(1991), 4 vom: Juli, Seite 266-278 volume:1 year:1991 number:4 month:07 pages:266-278 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Fluoxetine Bupropion Desipramine Biological Therapy Nortriptyline |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Drugs & aging |
| authorswithroles_txt_mv |
Koenig, Harold G. @@aut@@ |
| publishDateDaySort_date |
1991-07-01T00:00:00Z |
| hierarchy_top_id |
327644281 |
| dewey-sort |
3610 |
| id |
SPR03322515X |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR03322515X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519172912.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s1991 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00002512-199101040-00003</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR03322515X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00002512-199101040-00003-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">ASE</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Koenig, Harold G.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Treatment Considerations for the Depressed Geriatric Medical Patient</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1991</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Summary Depression is one of the most common reversible psychiatric disorders in the medically ill hospitalised elderly. Because of its adverse impact on quality of life, compliance with medical therapy, motivation towards recovery, and survival itself, depression requires rapid diagnosis and comprehensive management. Because of the risks attendant on the use of antidepressants and electroconvulsive therapy (ECT) in this population, medical and psychosocial strategies are of paramount and primary importance in the treatment of most critically ill depressed elderly individuals. These include adequate treatment of reversible medical illness, provision of psychological support, mobilisation of community resources, and involvement of family and social support networks. When depression is severe or associated with marked suicidal ideation, however, these four strategies may need to be carried out concurrently with biological therapies. After ensuring adequate cardiac, liver, and renal function, antidepressant therapy is best initiated at a low dosage (secondary amine preferred) and gradually titrated upward following serum concentrations carefully and monitoring for anticholinergic, hypotensive and cardiac adverse effects. If antidepressant therapy is not tolerated or is unsuccessful, then psychiatric consultation should be obtained and ECT considered, particularly if the patient is well enough to undergo repeated episodes of brief general anaesthesia.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Fluoxetine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bupropion</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Desipramine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biological Therapy</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nortriptyline</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Drugs & aging</subfield><subfield code="d">Berlin [u.a.] : Springer, 1991</subfield><subfield code="g">1(1991), 4 vom: Juli, Seite 266-278</subfield><subfield code="w">(DE-627)327644281</subfield><subfield code="w">(DE-600)2043689-0</subfield><subfield code="x">1179-1969</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1</subfield><subfield code="g">year:1991</subfield><subfield code="g">number:4</subfield><subfield code="g">month:07</subfield><subfield code="g">pages:266-278</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00002512-199101040-00003</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-ASE</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_702</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2190</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1</subfield><subfield code="j">1991</subfield><subfield code="e">4</subfield><subfield code="c">07</subfield><subfield code="h">266-278</subfield></datafield></record></collection>
|
| author |
Koenig, Harold G. |
| spellingShingle |
Koenig, Harold G. ddc 610 misc Fluoxetine misc Bupropion misc Desipramine misc Biological Therapy misc Nortriptyline Treatment Considerations for the Depressed Geriatric Medical Patient |
| authorStr |
Koenig, Harold G. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)327644281 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
springer |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
1179-1969 |
| topic_title |
610 ASE Treatment Considerations for the Depressed Geriatric Medical Patient Fluoxetine (dpeaa)DE-He213 Bupropion (dpeaa)DE-He213 Desipramine (dpeaa)DE-He213 Biological Therapy (dpeaa)DE-He213 Nortriptyline (dpeaa)DE-He213 |
| topic |
ddc 610 misc Fluoxetine misc Bupropion misc Desipramine misc Biological Therapy misc Nortriptyline |
| topic_unstemmed |
ddc 610 misc Fluoxetine misc Bupropion misc Desipramine misc Biological Therapy misc Nortriptyline |
| topic_browse |
ddc 610 misc Fluoxetine misc Bupropion misc Desipramine misc Biological Therapy misc Nortriptyline |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Drugs & aging |
| hierarchy_parent_id |
327644281 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Drugs & aging |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)327644281 (DE-600)2043689-0 |
| title |
Treatment Considerations for the Depressed Geriatric Medical Patient |
| ctrlnum |
(DE-627)SPR03322515X (SPR)00002512-199101040-00003-e |
| title_full |
Treatment Considerations for the Depressed Geriatric Medical Patient |
| author_sort |
Koenig, Harold G. |
| journal |
Drugs & aging |
| journalStr |
Drugs & aging |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
1991 |
| contenttype_str_mv |
txt |
| container_start_page |
266 |
| author_browse |
Koenig, Harold G. |
| container_volume |
1 |
| class |
610 ASE |
| format_se |
Elektronische Aufsätze |
| author-letter |
Koenig, Harold G. |
| doi_str_mv |
10.2165/00002512-199101040-00003 |
| dewey-full |
610 |
| title_sort |
treatment considerations for the depressed geriatric medical patient |
| title_auth |
Treatment Considerations for the Depressed Geriatric Medical Patient |
| abstract |
Summary Depression is one of the most common reversible psychiatric disorders in the medically ill hospitalised elderly. Because of its adverse impact on quality of life, compliance with medical therapy, motivation towards recovery, and survival itself, depression requires rapid diagnosis and comprehensive management. Because of the risks attendant on the use of antidepressants and electroconvulsive therapy (ECT) in this population, medical and psychosocial strategies are of paramount and primary importance in the treatment of most critically ill depressed elderly individuals. These include adequate treatment of reversible medical illness, provision of psychological support, mobilisation of community resources, and involvement of family and social support networks. When depression is severe or associated with marked suicidal ideation, however, these four strategies may need to be carried out concurrently with biological therapies. After ensuring adequate cardiac, liver, and renal function, antidepressant therapy is best initiated at a low dosage (secondary amine preferred) and gradually titrated upward following serum concentrations carefully and monitoring for anticholinergic, hypotensive and cardiac adverse effects. If antidepressant therapy is not tolerated or is unsuccessful, then psychiatric consultation should be obtained and ECT considered, particularly if the patient is well enough to undergo repeated episodes of brief general anaesthesia. |
| abstractGer |
Summary Depression is one of the most common reversible psychiatric disorders in the medically ill hospitalised elderly. Because of its adverse impact on quality of life, compliance with medical therapy, motivation towards recovery, and survival itself, depression requires rapid diagnosis and comprehensive management. Because of the risks attendant on the use of antidepressants and electroconvulsive therapy (ECT) in this population, medical and psychosocial strategies are of paramount and primary importance in the treatment of most critically ill depressed elderly individuals. These include adequate treatment of reversible medical illness, provision of psychological support, mobilisation of community resources, and involvement of family and social support networks. When depression is severe or associated with marked suicidal ideation, however, these four strategies may need to be carried out concurrently with biological therapies. After ensuring adequate cardiac, liver, and renal function, antidepressant therapy is best initiated at a low dosage (secondary amine preferred) and gradually titrated upward following serum concentrations carefully and monitoring for anticholinergic, hypotensive and cardiac adverse effects. If antidepressant therapy is not tolerated or is unsuccessful, then psychiatric consultation should be obtained and ECT considered, particularly if the patient is well enough to undergo repeated episodes of brief general anaesthesia. |
| abstract_unstemmed |
Summary Depression is one of the most common reversible psychiatric disorders in the medically ill hospitalised elderly. Because of its adverse impact on quality of life, compliance with medical therapy, motivation towards recovery, and survival itself, depression requires rapid diagnosis and comprehensive management. Because of the risks attendant on the use of antidepressants and electroconvulsive therapy (ECT) in this population, medical and psychosocial strategies are of paramount and primary importance in the treatment of most critically ill depressed elderly individuals. These include adequate treatment of reversible medical illness, provision of psychological support, mobilisation of community resources, and involvement of family and social support networks. When depression is severe or associated with marked suicidal ideation, however, these four strategies may need to be carried out concurrently with biological therapies. After ensuring adequate cardiac, liver, and renal function, antidepressant therapy is best initiated at a low dosage (secondary amine preferred) and gradually titrated upward following serum concentrations carefully and monitoring for anticholinergic, hypotensive and cardiac adverse effects. If antidepressant therapy is not tolerated or is unsuccessful, then psychiatric consultation should be obtained and ECT considered, particularly if the patient is well enough to undergo repeated episodes of brief general anaesthesia. |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA SSG-OPC-PHA SSG-OPC-ASE GBV_ILN_702 GBV_ILN_2190 |
| container_issue |
4 |
| title_short |
Treatment Considerations for the Depressed Geriatric Medical Patient |
| url |
https://dx.doi.org/10.2165/00002512-199101040-00003 |
| remote_bool |
true |
| ppnlink |
327644281 |
| mediatype_str_mv |
c |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| doi_str |
10.2165/00002512-199101040-00003 |
| up_date |
2024-07-03T17:24:50.408Z |
| _version_ |
1803579545783107584 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR03322515X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519172912.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s1991 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00002512-199101040-00003</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR03322515X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00002512-199101040-00003-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">ASE</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Koenig, Harold G.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Treatment Considerations for the Depressed Geriatric Medical Patient</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1991</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Summary Depression is one of the most common reversible psychiatric disorders in the medically ill hospitalised elderly. Because of its adverse impact on quality of life, compliance with medical therapy, motivation towards recovery, and survival itself, depression requires rapid diagnosis and comprehensive management. Because of the risks attendant on the use of antidepressants and electroconvulsive therapy (ECT) in this population, medical and psychosocial strategies are of paramount and primary importance in the treatment of most critically ill depressed elderly individuals. These include adequate treatment of reversible medical illness, provision of psychological support, mobilisation of community resources, and involvement of family and social support networks. When depression is severe or associated with marked suicidal ideation, however, these four strategies may need to be carried out concurrently with biological therapies. After ensuring adequate cardiac, liver, and renal function, antidepressant therapy is best initiated at a low dosage (secondary amine preferred) and gradually titrated upward following serum concentrations carefully and monitoring for anticholinergic, hypotensive and cardiac adverse effects. If antidepressant therapy is not tolerated or is unsuccessful, then psychiatric consultation should be obtained and ECT considered, particularly if the patient is well enough to undergo repeated episodes of brief general anaesthesia.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Fluoxetine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bupropion</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Desipramine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biological Therapy</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nortriptyline</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Drugs & aging</subfield><subfield code="d">Berlin [u.a.] : Springer, 1991</subfield><subfield code="g">1(1991), 4 vom: Juli, Seite 266-278</subfield><subfield code="w">(DE-627)327644281</subfield><subfield code="w">(DE-600)2043689-0</subfield><subfield code="x">1179-1969</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1</subfield><subfield code="g">year:1991</subfield><subfield code="g">number:4</subfield><subfield code="g">month:07</subfield><subfield code="g">pages:266-278</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00002512-199101040-00003</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-ASE</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_702</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2190</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1</subfield><subfield code="j">1991</subfield><subfield code="e">4</subfield><subfield code="c">07</subfield><subfield code="h">266-278</subfield></datafield></record></collection>
|
| score |
7.400199 |